CTRI/2023/03/050577Not yet recruitingPhase 4
A Prospective open-labelled three-armed pilot study to evaluate TIR parameters in T2DM patients on Lobeglitazone and Pioglitazone
Dr Suhas Erande0 sites0 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- Phase 4
- Status
- Not yet recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •T2DM patient with HbA1c >=7% to <=8.5% and on metformin monotherapy
Exclusion Criteria
- •Patients taking any other anti-diabetic medication at screening other than metformin
Investigators
Similar Trials
Completed
Phase 3
Ayurveda clinical trial on mildly symptomatic COVID- 19 patientsâ??CTRI/2021/02/031353Sri Sharada Ayurveda Pharmacy and RD Centre
Active, not recruiting
Not Applicable
A PILOT, RANDOMIZED, SINGLE SITE, 3 PARALLEL ARMS, OPEN-LABEL STUDY IN PATIENTS ON CHRONIC DIALYSIS WITH END STAGE RENAL DISEASE (ESRD) TO EVALUATE THE ENHANCING EFFECT OF TWO DOSES OF THYMOSIN ALPHA 1 ON THE IMMUNOGENICITY OF EGG-DERIVED H1N1sw MONOVALENT INFLUENZA VACCINE - NDZADAXIN ENHANCING EFFECT IN PATIENTS ON CHRONIC DIALYSIS WITH END STAGE RENAL DISEASE (ESRD) TREATED WITH EGG-DERIVED H1N1sw MONOVALENT INFLUENZA VACCINEMedDRA version: 12.1Level: LLTClassification code 10014647Term: End stage renal failureEUCTR2009-016362-85-ITSIGMA-TA
Completed
Phase 1
A prospective, single arm, single centre pilot trial to establish the safety and efficacy of the Oventus device to treat mild to moderate obstructive sleep apnoea and snoring.Mild to moderate obstructive sleep apnoeaSnoringRespiratory - Sleep apnoeaACTRN12615000028505Oventus Pty Ltd30
Not yet recruiting
Phase 4
A randomized clinical study to compare patient satisfaction and clinical outcome with three different nasal pack dressings available and that are used after nasal surgeryCTRI/2024/06/069152Dr Akhil Pratap Singh Trial Investigator
Active, not recruiting
Not Applicable
OPEN PILOT STUDY, TWO ARMS, WITH HISTORIC CONTROL, MULTICENTRIC TO EVALUATE SAFETY AND EFFICACY OF ASSOCIATION WITH EVEROLIMUS AND LOW DOSES OF CYCLOSPORIN AND STEROIDS AFTER INDUCTION WITH MONOCLONAL ANTIBODY ANTI CD25 IN PEDIATRIC PATIENTS AFTER KIDNEY TRANSPLANTS - NDpediatric patient after kidney transplantMedDRA version: 9.1Level: LLTClassification code 10023439Term: Kidney transplant rejectionEUCTR2008-006729-15-ITISTITUTO GIANNINA GASLINI